13204
β-tri-Calcium phosphate
puriss. p.a., ≥98% β-phase basis (unsintered powder)
동의어(들):
β-TCP, β-Tricalcium phosphate
로그인조직 및 계약 가격 보기
모든 사진(1)
About This Item
실험식(Hill 표기법):
Ca3O8P2
CAS Number:
Molecular Weight:
310.18
EC Number:
MDL number:
UNSPSC 코드:
12352302
PubChem Substance ID:
NACRES:
NA.55
분석:
≥98% β-phase basis (unsintered powder)
양식:
powder
추천 제품
grade
puriss. p.a.
Quality Level
분석
≥98% β-phase basis (unsintered powder)
양식
powder
불순물
≤250 mg/kg total sulfur (as SO4) (ICP)
≤50 mg/kg total heavy metals (as lead)
음이온 미량물
chloride (Cl-): ≤100 mg/L
양이온 미량물
As: ≤0.5 mg/kg
Ba: ≤10 mg/kg
Cd: ≤1 mg/kg
Co: ≤1 mg/kg
Cr: ≤5 mg/kg
Cu: ≤1 mg/kg
Hg: ≤0.5 mg/kg
Ni: ≤1 mg/kg
Pb: ≤5 mg/kg
Zn: ≤10 mg/kg
SMILES string
[Ca+2].[Ca+2].[Ca+2].[P](=O)([O-])([O-])[O-].[P](=O)([O-])([O-])[O-]
InChI
1S/3Ca.2H3O4P/c;;;2*1-5(2,3)4/h;;;2*(H3,1,2,3,4)/q3*+2;;/p-6
InChI key
QORWJWZARLRLPR-UHFFFAOYSA-H
유사한 제품을 찾으십니까? 방문 제품 비교 안내
일반 설명
β-tri-Calcium phosphate belongs to the category of calcium-phosphate based ceramics, which has been involved in the preparation of a new biosynthetic material possessing morphogenetic activity that is used as a bone implant.
분석 메모
Phase Composition (by XRD analysis)
Low crystalinity Hydroxylapatite at unsintered condition.
A high crystalinity ß-Tricalcium phosphate after sintering at 1100C.
ß-TCP: >98% (by x-ray diffraction analysis)
other Ca-P phases as Hydroxylapatite, a-TCP and Pyrophosphate <2.0%
Low crystalinity Hydroxylapatite at unsintered condition.
A high crystalinity ß-Tricalcium phosphate after sintering at 1100C.
ß-TCP: >98% (by x-ray diffraction analysis)
other Ca-P phases as Hydroxylapatite, a-TCP and Pyrophosphate <2.0%
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
가장 최신 버전 중 하나를 선택하세요:
이미 열람한 고객
A new polyphosphate calcium material with morphogenetic activity
Muller.G.EW, et al.
Materials Letters, 148, 163-166 (2015)
Timo Brandenburger et al.
Shock (Augusta, Ga.), 42(3), 234-238 (2014-07-01)
Remote ischemic preconditioning (RIPC) is an easily applicable method for protecting the heart against a subsequent ischemia and reperfusion (I/R) injury. However, the exact molecular mechanisms underlying RIPC are unknown. We examined the involvement of microRNAs (miRNAs) and in particular
Krzysztof W Luczynski et al.
Journal of biomedical materials research. Part A, 101(1), 138-144 (2012-07-25)
This paper is concerned with reliable and physically sound elasticity determination of rapid-prototyped tissue engineering scaffolds made of poly-L-lactide (PLLA), with and without small portions of tricalcium phosphate (TCP) inclusions. At the level of overall scaffolds, that is, that of
A H Choi et al.
Journal of dental research, 92(10), 853-859 (2013-07-17)
The purpose of coatings on implants is to achieve some or all of the improvements in biocompatibility, bioactivity, and increased protection from the release of harmful or unnecessary metal ions. During the last decade, there has been substantially increased interest
Floor C J van de Watering et al.
Journal of controlled release : official journal of the Controlled Release Society, 164(3), 283-290 (2012-07-18)
Clinical application of calcium phosphate cement (CPC; with incorporated polymeric porogens) in an injectable form implicates that loading methods for growth factors are limited. In view of this, the current study evaluated the in vitro and in vivo release kinetics
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.